Amyris

Amyris, Inc. engages in the provision of bioscience solutions. It offers its products to the health and wellness, clean beauty, and flavor and fragrance markets. The company was founded by Jack D. Newman, Kinkead Keith Reiling, and Neil Renninger on July 17, 2003 and is headquartered in Emeryville, CA.

Earnings data Q1 2024

The principal business of Tara Gold Resources Corp. is the acquisition, exploration and development of high-quality precious metals projects with potential for economic commercial value. Tara Gold is currently focused on acquiring and developing properties in the natural resource belt of the Sierra Madre Occidental and other prolific areas in the states of Chihuahua, Sonora, and Sinaloa, Mexico.  Tara Gold provides investors growth exposure with a diversified exploration portfolio, multiple multi-million ounce targets and several near term production scenarios. Tara Gold owns equity positions in Cayden Resources Inc. (TSX-V: CYD) and Tara Minerals Corp. (TARM.OB), a public US company which explores and develops high-quality precious & non-precious metals and mineral projects in Mexico.

Amyris: The Future, Accelerated

Amyris, Inc. (AMRS) CEO John Melo on Q1 2020 Results - Earnings Call Transcript

The company might have mobilized to respond to the coronavirus pandemic, but investors must focus on whether that results in tangible business progress.

The Worst Mistake Amyris Investors Can Make Right Now

Innovative Industrial Properties

These are the marijuana stocks with the best value, fastest growth, and most momentum for April.

Top Marijuana Stocks for April 2020

Cronos Group

These are the NASDAQ-listed marijuana stocks with the best value, fastest growth, and most momentum for April.

Top Marijuana Stocks on the NASDAQ for April 2020

The business needs to provide GAAP revenue and GAAP product gross margin for its consumer brands to reassure nervous investors.

Amyris Provides Update to Investors, but Not the Numbers Needed

Can the industrial biotech amend its manufacturing agreement to lower expenses? Will it matter?

Amyris Is Spending Way Too Much on Manufacturing Costs

Amyris' (AMRS) CEO John Melo on Q4 2019 Results - Earnings Call Transcript

Aurora Cannabis

Arena Pharmaceuticals

OrganiGram Holdings Inc.

Tilray Brands

Psychedelic Medicine Stocks Capture The Attention Of Investors

These are the marijuana stocks with the best value, fastest growth, and most momentum for March.

Top Marijuana Stocks for March 2020

Another year, another set of financing transactions that provide a lifeline to the struggling company.

Here's Why Amyris Shares Rose as Much as 12.5% Today

Investors need to pay close attention to Amyris (AMRS) stock based on the movements in the options market lately.

Options Traders Expect Huge Moves in Amyris (AMRS) Stock

These are the marijuana stocks with the best value, fastest growth, and most momentum for January.

Top Marijuana Stocks for January 2020

The synthetic biology pioneer launched an important new product, but it faces immense competition.

Here's Why Amyris Rose as Much as 12.7% Today

Aphria

Cara Therapeutics

GW Pharmaceuticals

Village Farms International

These are the marijuana stocks with the best value, fastest growth, and most momentum for November.

Top Marijuana Stocks for November 2019

Ramping up production of its zero-calorie sweetener has proved expensive. Can the company rein in costs?

Amyris Is Spending $1.29 to Generate Every $1 in Product Revenue

Amyris' (AMRS) CEO John Melo on Q3 2019 Results - Earnings Call Transcript

Starting with stevia, AMRS is positioned to significantly disrupt the high potency sweetener market with its new zero calorie, non-GMO, all-natural sweetener, PureCane.

Amyris Inc: A Sweet Future Brought To You By John Doerr

The filings provide a glimpse of the company's struggles. Can cannabinoids pull the business out of the doldrums?

Amyris Files First-Half 2019 Reports: What Investors Need to Know

Amyris, Inc. (AMRS) CEO John Melo on Q2 2019 Results - Earnings Call Transcript

The company filed its annual report for 2018 and gave a brief update on first-half 2019 operations.

Here's Why Amyris Rose 10.5% Before Slipping Into Negative Territory Today

Agilent Technologies

Archer-Daniels-Midland Company

Beyond Meat is just the beginning of a new emerging cohort of innovative companies. These innovators are changing how we feed the planet without consuming more of its resources.

Meet 3 Companies that Are Shaping the Future of Food

Amyris commands much lower multiples than similarly-hot tech/consumer product companies.

Pricing Amyris Into 2020

Amyris has built itself into a biosynthetic machine.

Amyris, Inc. - Taking It All In

An overlooked announcement provides an opportunity for a management team that has lost the trust of investors.

News for Amyris Stock (AMRS)